


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:48:55Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405383" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405383</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Pediatr</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>European Journal of Pediatrics</journal-title></journal-title-group><issn pub-type="ppub">0340-6199</issn><issn pub-type="epub">1432-1076</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405383</article-id><article-id pub-id-type="pmcid-ver">PMC12405383.1</article-id><article-id pub-id-type="pmcaid">12405383</article-id><article-id pub-id-type="pmcaiid">12405383</article-id><article-id pub-id-type="pmid">40892314</article-id><article-id pub-id-type="doi">10.1007/s00431-025-06409-w</article-id><article-id pub-id-type="publisher-id">6409</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Diagnostic accuracy of interleukin-6 (IL-6) as a significant biomarker in late-onset neonatal sepsis: an updated systematic review and meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9369-1933</contrib-id><name name-style="western"><surname>Alansari</surname><given-names initials="AN">Amani N.</given-names></name><address><email>aalansari9@hamad.qa</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0904-9153</contrib-id><name name-style="western"><surname>Zaazouee</surname><given-names initials="MS">Mohamed Sayed</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7981-9283</contrib-id><name name-style="western"><surname>Elshanbary</surname><given-names initials="AA">Alaa Ahmed</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3258-6873</contrib-id><name name-style="western"><surname>Mani</surname><given-names initials="S">Salma</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0006-1314-6713</contrib-id><name name-style="western"><surname>Messaoud</surname><given-names initials="M">Marwa</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02zwb6n98</institution-id><institution-id institution-id-type="GRID">grid.413548.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0571 546X</institution-id><institution>Department of Pediatric Surgery, </institution><institution>Hamad Medical Corporation, </institution></institution-wrap>Doha, Qatar </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05fnp1145</institution-id><institution-id institution-id-type="GRID">grid.411303.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2155 6022</institution-id><institution>Faculty of Medicine, </institution><institution>Al-Azhar University, </institution></institution-wrap>Assiut, Egypt </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00mzz1w90</institution-id><institution-id institution-id-type="GRID">grid.7155.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2260 6941</institution-id><institution>Faculty of Medicine, </institution><institution>Alexandria University, </institution></institution-wrap>Alexandria, Egypt </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05t1yee64</institution-id><institution-id institution-id-type="GRID">grid.420157.5</institution-id><institution>Pediatric Surgery Department, </institution><institution>Fattouma Bourguiba University Hospital, </institution></institution-wrap>Monastir, Tunisia </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00nhtcg76</institution-id><institution-id institution-id-type="GRID">grid.411838.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0593 5040</institution-id><institution>Faculty of Medicine of Monastir, </institution><institution>University of Monastir, </institution></institution-wrap>Monastir, Tunisia </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00nhtcg76</institution-id><institution-id institution-id-type="GRID">grid.411838.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0593 5040</institution-id><institution>Research Laboratory of Congenital Anomalies and Childhood Cancer LR12SP13, </institution><institution>University of Monastir, </institution></institution-wrap>Monastir, Tunisia </aff></contrib-group><author-notes><fn fn-type="com"><p>Communicated by Daniele De Luca</p></fn></author-notes><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>184</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496088</issue-id><elocation-id>587</elocation-id><history><date date-type="received"><day>26</day><month>4</month><year>2025</year></date><date date-type="rev-recd"><day>19</day><month>7</month><year>2025</year></date><date date-type="accepted"><day>9</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="431_2025_Article_6409.pdf"/><abstract id="Abs1"><p id="Par9">Late-onset neonatal sepsis (LONS) remains a leading cause of morbidity and mortality in neonates, particularly among preterm and low birth weight infants. Interleukin-6 (IL-6) has emerged as a promising biomarker for early detection of LONS, yet the diagnostic performance of IL-6 remains inconsistent across studies. This meta-analysis aimed to evaluate the overall diagnostic accuracy of IL-6 in detecting LONS and to assess the certainty of evidence using the GRADE approach. A comprehensive search of five databases was conducted up to July 15, 2025. Twenty-two studies were eligible for inclusion, of which 20 (<italic toggle="yes">n</italic>&#8201;=&#8201;3527 neonates) were included in the meta-analysis. A bivariate random-effects model was used to estimate pooled sensitivity and specificity, and the area under the SROC curve was used to assess overall diagnostic accuracy. Pooled sensitivity and specificity were 85.2% (95% CI: 80.0&#8211;89.3%) and 84.1% (95% CI: 77.5&#8211;89.0%), respectively. The positive and negative likelihood ratios were 5.43 and 0.18, with a diagnostic odds ratio of 31.4. The AUC was 0.91, indicating excellent diagnostic accuracy. Subgroup and sensitivity analyses confirmed the robustness of the findings, and no significant threshold effect was detected. However, suspected publication bias was noted. The GRADE assessment rated the certainty of evidence as moderate. <italic toggle="yes">Conclusion</italic>: IL-6 demonstrates high diagnostic accuracy for LONS and may serve as a valuable tool for early identification, though standardization of cutoff thresholds and further validation studies are warranted. 
<table-wrap id="Taba" position="float" orientation="portrait"><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="1" rowspan="1"><p><bold>What is Known:</bold></p><p>&#8226; <italic toggle="yes">IL-6 is an early-rising biomarker for late-onset neonatal sepsis (LONS), but its diagnostic accuracy varies across studies.</italic></p></td></tr><tr><td align="left" colspan="1" rowspan="1"><p><bold>What is New:</bold></p><p>&#8226; <italic toggle="yes">This meta-analysis used a bivariate model to estimate IL-6 performance, yielding high pooled sensitivity (85.2%) and specificity (84.1%).</italic></p></td></tr></tbody></table></table-wrap></p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s00431-025-06409-w.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Biomarker</kwd><kwd>Diagnostic accuracy</kwd><kwd>Interleukin-6</kwd><kwd>IL-6</kwd><kwd>Late-onset neonatal sepsis</kwd></kwd-group><funding-group><award-group><funding-source><institution>Hamad Medical Corporation</institution></funding-source></award-group><open-access><p>Open Access funding provided by the Qatar National Library.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par10">Neonatal sepsis is one of the leading contributors to morbidity and mortality in newborns, being responsible for 13% of all neonatal mortality, and 42% of deaths in the first week of life [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Despite the advances in neonatal care, neonatal sepsis is widely encountered in neonatal intensive care units (NICU). Its incidence ranges from 1 to 10 per 1000 live births worldwide, with the actual caseload being significantly higher in low-resource settings [<xref ref-type="bibr" rid="CR3">3</xref>]. Early diagnosis is crucial to avoid the devastating consequences, including multi-organ dysfunction, long-term neurodevelopmental impairment, and increased mortality [<xref ref-type="bibr" rid="CR4">4</xref>]. Neonatal sepsis is classified as early-onset (EONS) or late-onset (LONS), based on whether it occurs before or after 72 h of life [<xref ref-type="bibr" rid="CR5">5</xref>]. Unlike early-onset cases, which usually result from vertically transmitted group B <italic toggle="yes">Streptococcus</italic> (GBS) or <italic toggle="yes">Escherichia coli</italic> (<italic toggle="yes">E. coli</italic>), which are predictable and covered by standard empirical antibiotic therapy, LONS is usually acquired postnatally from the hospital environment or the infant&#8217;s own acquired microbiota [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Blood culture remains the gold standard for diagnosis; yet, its sensitivity is influenced by factors such as the volume of blood collected, prior antibiotic exposure, the severity of bacteremia, and the laboratory&#8217;s technical capabilities [<xref ref-type="bibr" rid="CR7">7</xref>]. Therefore, in the context of neonatal sepsis, there is a critical need for early-rising and accurate biomarkers to enable prompt and reliable diagnosis, particularly in cases where culture results are delayed or inconclusive. These biomarkers would help in risk stratification, guide in the early intervention, and ultimately improve neonatal outcomes [<xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par11">Many biomarkers have been explored for the diagnosis of neonatal sepsis. C-reactive protein (CRP) and procalcitonin (PCT) are among the widely used markers; both, however, are not without limitations [<xref ref-type="bibr" rid="CR7">7</xref>]. CRP begins to surge around 10&#8211;12 h after infection onset, peaking at 24&#8211;48 h, making it suboptimal for early diagnosis [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. PCT is influenced by conditions like stress implying birth and by perinatal asphyxia due to its association with non-infectious inflammatory states [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Other biomarkers, including interleukins, hepcidin, and CD64, were investigated. They showed promise, but their diagnostic performance varies in different studies [<xref ref-type="bibr" rid="CR13">13</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>]. Interleukin-6 (IL-6) is emerging as a candidate for a possible early marker of neonatal sepsis. It plays a key role in innate immunity, stimulating acute-phase reactions against infection and modulating pro-inflammatory cascades [<xref ref-type="bibr" rid="CR16">16</xref>]. Its most marked distinguishing feature is the quick rise after the onset of infection [<xref ref-type="bibr" rid="CR17">17</xref>]. Nevertheless, the diagnostic performance of IL-6 remains quite controversial across various studies, from excellent sensitivity and specificity to inadequate sensitivity and high false-positive rates [<xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR21">21</xref>]. Meeting these gaps, we conducted this meta-analysis to pool the available evidence about the diagnostic performance of IL-6 in neonatal sepsis, particularly in LONS.</p><sec id="Sec2"><title>Methods</title><p id="Par12">This meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [<xref ref-type="bibr" rid="CR22">22</xref>].</p></sec><sec id="Sec3"><title>Search strategy</title><p id="Par13">A comprehensive search was conducted in PubMed, Embase, Scopus, the Cochrane Library, and Web of Science up to July 10, 2025. Additional manual screening was performed through Google Scholar, ClinicalTrials.gov, and relevant grey literature sources. All retrieved records were imported into EndNote, and duplicates were removed. Two independent reviewers screened titles and abstracts for relevance based on predefined inclusion and exclusion criteria. Full-text articles of potentially eligible studies were then assessed for final inclusion. Any discrepancies between reviewers were resolved through discussion, with a third reviewer consulted if necessary. Full details of the database-specific search strategies and number of retrieved records are provided in Table <xref rid="MOESM1" ref-type="media">S1</xref>.</p><sec id="Sec4"><title>Eligibility criteria</title><p id="Par14">Studies assessing the diagnostic performance of IL-6 in late-onset neonatal sepsis, defined as sepsis occurring after 72&#160;h of life, were considered for inclusion. Eligible studies had to report sensitivity and specificity or provide raw data on true positives, false positives, true negatives, and false negatives. Studies were excluded if they were non-English, case series or case reports, not limited to neonates, focused on sepsis within the first 72&#160;h of life, or lacked diagnostic accuracy data.</p></sec></sec><sec id="Sec5"><title>Data extraction and quality assessment</title><p id="Par15">Three independent reviewers extracted relevant data, which were then summarized and tabulated. The extracted information included study details such as author, year of publication, study design, country, neonatal age, time frame of the LONS, number of patients recruited, clinical presentation, and main findings. Data on diagnostic testing included the reference standard, test used for IL-6 measurement, IL-6 cutoff value, sensitivity, specificity, area under the curve (AUC), positive predictive value (PPV), and negative predictive value (NPV). In studies combining IL-6 with other biomarkers, we extracted the data corresponding to IL-6 alone. The methodological quality of the included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool, which evaluates four domains: patient selection, index test(s), reference standard, and flow and timing [<xref ref-type="bibr" rid="CR23">23</xref>]. Additionally, the certainty of the evidence for pooled estimates of sensitivity and specificity was evaluated using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach for diagnostic test accuracy [<xref ref-type="bibr" rid="CR24">24</xref>]. Both assessments were performed independently by two reviewers, with disagreements resolved through consensus or by consulting a third reviewer.</p></sec><sec id="Sec6"><title>Statistical analysis</title><p id="Par16">For the included studies, per-study estimates of sensitivity and specificity of IL-6 were provided in a paired forest plot. Our analysis stems from the true/false positive/negative frequencies reported in included studies (no missing values found). Due to the special characteristics of diagnostic test accuracy meta-analysis, pooled estimates (and 95% confidence intervals) of test performance metrics were obtained from a bivariate model [<xref ref-type="bibr" rid="CR25">25</xref>]. Bivariate modelling takes into account the &#8220;threshold effect&#8221;&#8212;the negative correlation between sensitivity and specificity&#8212;which makes it superior to separately pooling sensitivity and specificity through random-effects models [<xref ref-type="bibr" rid="CR26">26</xref>]. Summary ROC (SROC) curves were also fit. Being an ongoing field of research and an area of daily technological advancements, methods to perform sensitivity analysis and assess for publication bias given the output of the bivariate model are still being developed. The trim and fill method is a robust approach to investigate publication bias [<xref ref-type="bibr" rid="CR27">27</xref>]. It is based on the funnel plot and is favorable over other available methods in diagnostic test accuracy meta-analysis [<xref ref-type="bibr" rid="CR28">28</xref>]. To address the sensitivity of our findings to potential publication bias, we utilized left-sided trim and fill to identify influential cases in terms of diagnostic test accuracy. Additionally, we conducted sensitivity analyses based on study-level risk of bias (QUADAS-2 domains) and study design (e.g., prospective vs. retrospective) to evaluate the robustness of the pooled estimates under varying methodological quality. Analysis and reporting were done using the R programming language for statistical computing, mainly the mada package [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Trim and fill functionality was imported from the metafor package [<xref ref-type="bibr" rid="CR31">31</xref>].</p></sec></sec><sec id="Sec7"><title>Results</title><sec id="Sec8"><title>Search results</title><p id="Par17">A total of 4632 records were identified through the database search. After removing duplicates, 3060 records remained for title and abstract screening. Of these, 65 full-text articles were assessed for eligibility based on the predefined inclusion criteria. Ultimately, 22 studies were included in this systematic review, with 20 studies eligible for meta-analysis. The study selection process is illustrated in the PRISMA 2020 flow diagram (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>The PRISMA flowchart</p></caption><graphic id="MO1" position="float" orientation="portrait" xlink:href="431_2025_6409_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec9"><title>General characteristics</title><p id="Par18">A total of 22 studies were included [<xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR32">32</xref>&#8211;<xref ref-type="bibr" rid="CR50">50</xref>]. The majority were prospective cohort studies, with some case&#8211;control studies and retrospective analyses. The studies were conducted in diverse regions, including China, India, Turkey, Bulgaria, Austria, France, Greece, USA, Brazil, Egypt, and Indonesia. Their general characteristics are summarized in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>.
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>Summary of the included studies</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">ID</th><th align="left" colspan="1" rowspan="1">Study design</th><th align="left" colspan="1" rowspan="1">Country</th><th align="left" colspan="1" rowspan="1">Neonate&#8217;s age</th><th align="left" colspan="1" rowspan="1">LOS time frame</th><th align="left" colspan="1" rowspan="1">Patients recruited</th><th align="left" colspan="1" rowspan="1">Clinical presentation</th><th align="left" colspan="1" rowspan="1">Main results</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"> Chen 2025</td><td align="left" colspan="1" rowspan="1">Case&#8211;control study</td><td align="left" colspan="1" rowspan="1">China</td><td align="left" colspan="1" rowspan="1">13.92&#8201;&#177;&#8201;5.04&#160;days (term) and 14.39&#8201;&#177;&#8201;3.85&#160;days (premature) infants&#8203;</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1">A total of 240 neonates were recruited (120 with neonatal sepsis&#8212;60 premature and 60 term infants&#8212;and 120 non-infected controls&#8212;60 premature and 60 term infants)&#8203;</td><td align="left" colspan="1" rowspan="1">Abnormal body temperature, respiratory changes, lethargy, feeding difficulties, and hemodynamic instability</td><td align="left" colspan="1" rowspan="1"><p>IL-6 was found to be a reliable diagnostic biomarker for neonatal sepsis</p><p>The combination of IL-6 with other biomarkers (e.g., CRP, PCT) improved diagnostic performance&#8203;</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Santos 2024</td><td align="left" colspan="1" rowspan="1">Multicenter prospective cohort study</td><td align="left" colspan="1" rowspan="1">Brazil</td><td align="left" colspan="1" rowspan="1">From 3&#160;days onward</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1"><p>53 neonates with blood culture-proven LOS</p><p>22 healthy full-term controls sampled on day 3 before hospital discharge&#8203;</p></td><td align="left" colspan="1" rowspan="1">Fever, cardiovascular, respiratory, gastrointestinal, and neurological issues, with the most common pathogens being coagulase-negative Staphylococcus and Staphylococcus aureus</td><td align="left" colspan="1" rowspan="1">IL-6 demonstrated excellent diagnostic and prognostic accuracy for (LOS), distinguishing survivors from non-survivors with an AUC&#8201;&gt;&#8201;0.90 at all-time points, whereas ADM and CRP showed limited prognostic value&#8203;</td></tr><tr><td align="left" colspan="1" rowspan="1"> Goyal 2024</td><td align="left" colspan="1" rowspan="1">Prospective cohort study</td><td align="left" colspan="1" rowspan="1">India</td><td align="left" colspan="1" rowspan="1">N.D</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1">82 neonates with clinically suspected sepsis</td><td align="left" colspan="1" rowspan="1">Respiratory distress (71.95%), feeding intolerance (35.37%), and hemodynamic instability (30.49%)</td><td align="left" colspan="1" rowspan="1">CRP had the highest diagnostic accuracy (AUC 0.73), followed by PCT (AUC 0.65) and IL-6 (AUC 0.55). IL-6 had high sensitivity but low specificity</td></tr><tr><td align="left" colspan="1" rowspan="1">Rupin 2024</td><td align="left" colspan="1" rowspan="1">Prospective cohort study</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">Within 7&#160;days of birth</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1"><p>118 VLBW infants (54 analyzed)</p><p>Mean gestational age&#8201;=&#8201;25.9&#8201;&#177;&#8201;1.9&#160;weeks</p><p>Mean birth weight&#8201;=&#8201;803&#8201;&#177;&#8201;222&#160;g</p></td><td align="left" colspan="1" rowspan="1">Tachycardia, feeding intolerance, pnea, respiratory distress, and abdominal distension&#8203;</td><td align="left" colspan="1" rowspan="1">IL-6 had 100% sensitivity and 78% specificity for diagnosing Gram-negative sepsis or NEC at a threshold of 200&#160;pg/mL, and combining it with the Pulse Oximetry Warning Score improved predictive accuracy&#8203;</td></tr><tr><td align="left" colspan="1" rowspan="1"> Gatseva 2023</td><td align="left" colspan="1" rowspan="1">Prospective cohort study</td><td align="left" colspan="1" rowspan="1">Bulgaria</td><td align="left" colspan="1" rowspan="1">Neonates with a stay in the NICU exceeding 72&#160;h</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1"><p>Total: 60 newborns</p><p>Group 1: Symptomatic and infected (n&#8201;=&#8201;21)</p><p>Group 2: Symptomatic but uninfected (n&#8201;=&#8201;20)</p><p>Group 0: Asymptomatic controls (n&#8201;=&#8201;19)</p></td><td align="left" colspan="1" rowspan="1">Temperature instability, apnea, tachypnea, tachycardia, dyspnea, hyper-/hypothermia, feeding difficulties, and irritability&#8203;</td><td align="left" colspan="1" rowspan="1">IL-6 and (PCT) were the most sensitive markers for early LOS diagnosis; combining IL-6, PCT and platelet count (PLT) increased diagnostic accuracy (AUC&#8201;=&#8201;0.880)</td></tr><tr><td align="left" colspan="1" rowspan="1">Kung 2023</td><td align="left" colspan="1" rowspan="1">Retrospective cohort study</td><td align="left" colspan="1" rowspan="1">Austria</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;7&#160;days</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;7&#160;days</td><td align="left" colspan="1" rowspan="1">1,695 neonates in total, including 752 very-preterm infants and 701 very-low-birthweight infants</td><td align="left" colspan="1" rowspan="1">Fever or hypothermia, respiratory distress, poor feeding, lethargy, pale or mottled skin, and jaundice, along with abnormal blood work such as elevated white blood cell count and CRP</td><td align="left" colspan="1" rowspan="1">IL-6 cut-off values were defined for diagnosing culture-confirmed sepsis with good sensitivity and specificity</td></tr><tr><td align="left" colspan="1" rowspan="1"> Pons 2023</td><td align="left" colspan="1" rowspan="1">prospective, multicenter cohort study</td><td align="left" colspan="1" rowspan="1">France</td><td align="left" colspan="1" rowspan="1">7&#8211;178&#160;days</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1">234 hospitalized neonates with suspected LOS were enrolled; 230 had analyzable samples. Of these, 51 were classified as infected, 153 as not infected, and 26 were unclassified&#8203;</td><td align="left" colspan="1" rowspan="1">Fever, tachycardia, capillary refill time&#8201;&gt;&#8201;3&#160;s, gray/pale skin complexion, apnea/bradycardia, and respiratory distress</td><td align="left" colspan="1" rowspan="1">IL-6 was one of the best-performing biomarkers with an AUC of 0.864, and using biomarkers could have avoided up to 64% of unjustified antibiotic use&#8203;</td></tr><tr><td align="left" colspan="1" rowspan="1">Cui 2021</td><td align="left" colspan="1" rowspan="1">case&#8211;control study</td><td align="left" colspan="1" rowspan="1">China</td><td align="left" colspan="1" rowspan="1">14.32&#8201;&#177;&#8201;9.74</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1">The study enrolled 126 preterm infants, with 89 infants in the sepsis group (47 confirmed sepsis and 42 clinical sepsis) and 31 infants in the control group</td><td align="left" colspan="1" rowspan="1">Respiratory distress, Tachycardia or bradycardia, Poor perfusion, Feeding intolerance, Jaundice and&#160;abnormal body temperature</td><td align="left" colspan="1" rowspan="1">The study found that IL-6, CRP, and PCT are reliable indicators for early diagnosis of nosocomial infections in preterm infants, with IL-6 peaking 6&#160;h after infection onset and returning to normal 24&#8211;48&#160;h after infection control and combining PCT with IL-6 or CRP improving diagnostic accuracy</td></tr><tr><td align="left" colspan="1" rowspan="1"> De&#287;irmencio&#287;lu 2019</td><td align="left" colspan="1" rowspan="1">Prospective, case&#8211;control study</td><td align="left" colspan="1" rowspan="1">Turkey</td><td align="left" colspan="1" rowspan="1">4 to 60&#160;days</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1"><p>26 preterm infants with culture-proven LOS</p><p>29 preterm infants without sepsis (control group)</p></td><td align="left" colspan="1" rowspan="1"><p>Respiratory (tachypnea, apnea, increased ventilatory support)</p><p>Metabolic (feeding problems, temperature instability, metabolic acidosis)</p><p>Circulatory (hypotension, poor perfusion, bradycardia)</p><p>Neurologic (lethargy, irritability)</p></td><td align="left" colspan="1" rowspan="1">Presepsin showed high diagnostic accuracy for culture-proven late-onset sepsis in preterm infants with 88.9% sensitivity and 88.9% specificity at a cutoff value of 823&#160;ng/ml, while fetuin-A levels were not significantly different between septic and control groups</td></tr><tr><td align="left" colspan="1" rowspan="1"> Saldir 2015</td><td align="left" colspan="1" rowspan="1">Prospective cohort study</td><td align="left" colspan="1" rowspan="1">Turkey</td><td align="left" colspan="1" rowspan="1">99&#8201;&#177;&#8201;24&#160;h</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1"><p>Total&#8201;=&#8201;50 neonates</p><p>30 septic neonates (6 with proven sepsis, 24 with probable sepsis)</p><p>20 nonseptic neonates (control group)</p></td><td align="left" colspan="1" rowspan="1">Feeding intolerance, respiratory distress, hypotension, and clinical deterioration&#8203;</td><td align="left" colspan="1" rowspan="1">Elevated levels of sTREM-1 and endocan, along with IL-6 ratio, are effective for diagnosing neonatal sepsis, with sTREM-1 showing the highest diagnostic accuracy</td></tr><tr><td align="left" colspan="1" rowspan="1"> Tunc 2014</td><td align="left" colspan="1" rowspan="1">Prospective cohort study</td><td align="left" colspan="1" rowspan="1">Turkey</td><td align="left" colspan="1" rowspan="1">98.9&#8201;&#177;&#8201;22.2&#160;h</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1"><p>30 septic neonates (5 with proven sepsis, 25 with probable sepsis)</p><p>20 non-septic neonates (admitted for conditions other than sepsis)</p></td><td align="left" colspan="1" rowspan="1">Temperature instability, apnea, tachycardia/bradycardia, hypotension, feeding intolerance, abdominal distension, and clinical deterioration</td><td align="left" colspan="1" rowspan="1">Elevated serum levels of CXCR4 and CXCL12 are significantly associated with neonatal sepsis and decrease after treatment, making them potential biomarkers for early diagnosis</td></tr><tr><td align="left" colspan="1" rowspan="1"> Lusyati 2013</td><td align="left" colspan="1" rowspan="1">Prospective cohort study</td><td align="left" colspan="1" rowspan="1">Indonesia</td><td align="left" colspan="1" rowspan="1">Older than 72&#160;h</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1"><p>Proven Sepsis (PS) group &#8211; 18 infants</p><p>Clinical Sepsis group &#8211; 25 infants</p><p>Control group &#8211; 34 infants</p></td><td align="left" colspan="1" rowspan="1">Temperature instability, apnea, bradycardia, desaturations, respiratory dysfunction, hypotension, poor capillary refill, feeding intolerance, abdominal signs of NEC, hyperglycemia, metabolic acidosis, seizures</td><td align="left" colspan="1" rowspan="1">IL-6, IL-8, IL-15 and TNF-&#945; are potentially good markers to differentiate proven LOS from clinical sepsis, with IL-6 and IL-15 showing the best sensitivity and specificity at 12 and 24&#160;h</td></tr><tr><td align="left" colspan="1" rowspan="1">Maaboud 2012</td><td align="left" colspan="1" rowspan="1">Case&#8211;control study</td><td align="left" colspan="1" rowspan="1">Egypt</td><td align="left" colspan="1" rowspan="1">3&#8211;30&#160;days</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1">48 full-term neonates with late-onset sepsis and 40 healthy neonates as controls</td><td align="left" colspan="1" rowspan="1">Feeding intolerance, lethargy, irritability, temperature instability, prolonged capillary refill, jaundice, tachypnea, recurrent apnea, tachycardia, or bradycardia</td><td align="left" colspan="1" rowspan="1">IL-6 and calprotectin levels were significantly elevated in neonates with late-onset sepsis, with IL-6 showing high sensitivity (89%) and specificity (92.2%) at a cutoff of 160&#160;pg/mL</td></tr><tr><td align="left" colspan="1" rowspan="1"> Raynor 2012</td><td align="left" colspan="1" rowspan="1">Prospective cohort study</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;3&#160;days old</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1">A total of 226 plasma samples were obtained from 163 NICU patients with suspected sepsis. The gestational age of the infants was 28.7&#8201;&#177;&#8201;4.7&#160;weeks, and the birth weight was 1,311&#8201;&#177;&#8201;861&#160;g (mean&#8201;&#177;&#8201;SD)</td><td align="left" colspan="1" rowspan="1">Gastrointestinal (feeding intolerance, necrotizing enterocolitis), respiratory (apnea, distress), CNS (temperature instability, lethargy), skin infections, and abnormal lab findings (hyperglycemia, acidosis, bandemia)&#8203;</td><td align="left" colspan="1" rowspan="1">Cytokine screening using IL-6, IL-8, TNF-&#945; had 100% sensitivity and 69% Positive predictive value for detecting Gram-negative bacteremia in NICU patient</td></tr><tr><td align="left" colspan="1" rowspan="1"> Hotoura 2011</td><td align="left" colspan="1" rowspan="1">Prospective cohort study</td><td align="left" colspan="1" rowspan="1">Greece</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;3&#160;days old</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1"><p>82 preterm neonates classified into:</p><p>Sepsis group: 17 neonates with confirmed sepsis (positive blood culture with symptoms)</p><p>Suspected infection group: 25 neonates with infection symptoms but negative cultures</p><p>Control group: 40 infection-free neonates</p></td><td align="left" colspan="1" rowspan="1">Poor peripheral infusion, capillary refill&#8201;&gt;&#8201;3&#160;s, abnormal skin color, hypotension, temperature instability, hypoglycemia, feeding issues, respiratory distress, and seizures</td><td align="left" colspan="1" rowspan="1">IL-6&#8201;&gt;&#8201;30&#160;pg/ml combined with CRP&#8201;&gt;&#8201;10&#160;mg/l was the most accurate predictor of sepsis, with sensitivity 1.0 and specificity 0.96</td></tr><tr><td align="left" colspan="1" rowspan="1"> Sarafidis 2010</td><td align="left" colspan="1" rowspan="1">Prospective cohort study</td><td align="left" colspan="1" rowspan="1">Greece</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;3&#160;days of life</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1"><p>Total: 52 neonates</p><p>31 infected neonates (22 with confirmed sepsis&#8201;+&#8201;9 with possible sepsis)</p><p>21 non-infected neonates</p></td><td align="left" colspan="1" rowspan="1">Temperature instability, respiratory distress, gastrointestinal dysfunction, cardiovascular changes, and abnormal lab results (metabolic acidosis, thrombocytopenia, leukopenia)&#8203;</td><td align="left" colspan="1" rowspan="1">Serum sTREM-1 and IL-6 levels were significantly elevated in infected neonates, but sTREM-1 alone was not superior to IL-6 for diagnosing late-onset sepsis</td></tr><tr><td align="left" colspan="1" rowspan="1"> Ng 2007</td><td align="left" colspan="1" rowspan="1">prospective cohort study</td><td align="left" colspan="1" rowspan="1">China</td><td align="left" colspan="1" rowspan="1">&#8201;&#8805;&#8201;72&#160;h old</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1"><p>Total suspected infection episodes: 155</p><p>Infected group (Group 1): 44 episodes (36 infants)</p><p>Noninfected group (Group 2): 111 episodes (50 infants)</p></td><td align="left" colspan="1" rowspan="1">Temperature instability, apnea, respiratory distress, GI symptoms (abdominal distention, bloody stools), cardiovascular dysfunction, abnormal lab findings (metabolic acidosis, thrombocytopenia, leukopenia/leukocytosis)</td><td align="left" colspan="1" rowspan="1">IL-6 (cutoff 26.1&#160;pg/mL) showed 82% sensitivity, 82% specificity, AUC&#8201;=&#8201;0.88, making it a useful marker for diagnosing late-onset neonatal sepsis</td></tr><tr><td align="left" colspan="1" rowspan="1">Maciolek 2006</td><td align="left" colspan="1" rowspan="1">Prospective cohort study</td><td align="left" colspan="1" rowspan="1">Netherlands</td><td align="left" colspan="1" rowspan="1">0 to 60&#160;days</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1">111 infants in total (92 NICU patients and 19 pediatric ward patients)</td><td align="left" colspan="1" rowspan="1">Fever, temperature instability, irritability, lethargy, apnea, abdominal distension, respiratory distress, poor feeding, diarrhea, etc</td><td align="left" colspan="1" rowspan="1">IL-6, IL-8, and PCT outperformed CRP in diagnosing neonatal sepsis and differentiating bacterial from viral infections</td></tr><tr><td align="left" colspan="1" rowspan="1"> Arnon 2005</td><td align="left" colspan="1" rowspan="1">Prospective cohort study</td><td align="left" colspan="1" rowspan="1">Israel</td><td align="left" colspan="1" rowspan="1">5&#8211;36&#160;days</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1"><p>Total: 116 infants</p><p>Proven sepsis group&#8201;=&#8201;23</p><p>Clinical sepsis group&#8201;=&#8201;15</p><p>non-sepsis group&#8201;=&#8201;78 (37 preterm infants without sepsis and 41 healthy controls)</p></td><td align="left" colspan="1" rowspan="1">Pallor, poor skin perfusion, apnea, bradycardia, hypotension, respiratory dysfunction, and metabolic abnormalities (acidosis, hyperglycemia)&#8203;</td><td align="left" colspan="1" rowspan="1">Serum amyloid A was a reliable early marker for late-onset sepsis in preterm infants, with high sensitivity (95&#8211;100%) (97&#8211;100%) in the first 24&#160;h&#8203;</td></tr><tr><td align="left" colspan="1" rowspan="1"> Gonzalez 2003</td><td align="left" colspan="1" rowspan="1">Two-phase study: retrospective (S1) and prospective (S2) cohort</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">&#8201;&#8805;&#8201;72&#160;h old</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1"><p>S1: Retrospective review of 48 episodes of culture-proven late-onset sepsis from 1991&#8211;1998</p><p>S2: 27 infants enrolled in a prospective study, with 8 confirmed sepsis cases and 19 non-sepsis cases</p></td><td align="left" colspan="1" rowspan="1">Apnea, bradycardia, respiratory distress, increased ventilatory requirements, desaturations, and gastric residuals</td><td align="left" colspan="1" rowspan="1">IL-6 levels on days 0 and 1 were significantly higher in infants with confirmed sepsis, making it a potential early marker for diagnosing late-onset neonatal sepsis</td></tr><tr><td align="left" colspan="1" rowspan="1"> Ng 2002</td><td align="left" colspan="1" rowspan="1">prospective cohort study</td><td align="left" colspan="1" rowspan="1">China</td><td align="left" colspan="1" rowspan="1">At least 72&#160;h old</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1">80 VLBW infants&#160;with&#160;127 episodes of suspected clinical sepsis. Of these,&#160;37 episodes&#160;were confirmed as infections</td><td align="left" colspan="1" rowspan="1">Unstable temperature, hypotension, recurrent apnea, and severe desaturation</td><td align="left" colspan="1" rowspan="1">Neutrophil CD64 expression&#160;was found to be a highly sensitive marker for diagnosing late-onset nosocomial infection in VLBW infants, with sensitivity and negative predictive values exceeding 95% at 0 and 24&#160;h after sepsis evaluation</td></tr><tr><td align="left" colspan="1" rowspan="1"> Ng 1997</td><td align="left" colspan="1" rowspan="1">Prospective cohort study</td><td align="left" colspan="1" rowspan="1">China</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h of age</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;72&#160;h</td><td align="left" colspan="1" rowspan="1"><p>Total of 101 episodes of suspected clinical sepsis were investigated in 68 (VLBW) infants</p><p>45 episodes were confirmed as infections</p></td><td align="left" colspan="1" rowspan="1">Unstable temperature, lethargy, feeding intolerance, respiratory issues, cardiovascular instability (bradycardia, tachycardia), and hematologic changes (thrombocytopenia, leukopenia)&#8203;</td><td align="left" colspan="1" rowspan="1">IL-6 had the highest sensitivity (89%) and NPV(91%) for detecting late-onset sepsis on day 0, while CRP was most effective after 24&#8211;48&#160;h</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">CRP</italic> C-reactive protein, <italic toggle="yes">PCT</italic> procalcitonin, <italic toggle="yes">IL-6</italic> interleukin-6, <italic toggle="yes">VLBW</italic> very low birth weight, <italic toggle="yes">LOS</italic> late onset-sepsis, <italic toggle="yes">AUC</italic> area under curve, <italic toggle="yes">ADM</italic> adrenomedullin, <italic toggle="yes">NICU</italic> neonatal intensive care unit, <italic toggle="yes">NEC</italic> necrotizing enterocolitis, <italic toggle="yes">CXCR4</italic> chemokine receptor type 4, <italic toggle="yes">CXCL12</italic> chemokine receptor ligand 12, <italic toggle="yes">TNF-&#945;</italic> tumor necrosis factor-alpha, <italic toggle="yes">sTREM-1</italic> soluble triggering receptor expressed on myeloid cells-1, <italic toggle="yes">NS-PI</italic> neonatal sepsis-premature infant, <italic toggle="yes">NS-TI</italic> neonatal sepsis-term infant, <italic toggle="yes">N.D</italic> not determined</p></table-wrap-foot></table-wrap></p><p id="Par19">Table <xref rid="Tab2" ref-type="table">2</xref> summarizes the details of diagnostic testing and the accuracy parameters. All studies used blood culture-confirmed sepsis as the reference standard. Cutoff values for IL-6 varied widely, with the studies by Rupin et al. and Maaboud et al. using the highest values [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. At a cutoff of 7 pg/mL, Tunc et al. reported high sensitivity (93.3%) and specificity (95%) [<xref ref-type="bibr" rid="CR49">49</xref>]. Similarly, at 10 pg/mL, Santos et al. reported a sensitivity of 96.2% and a specificity of 90.9% [<xref ref-type="bibr" rid="CR36">36</xref>]. For 18&#8211;31 pg/mL, sensitivity ranged from 75 to 89%, while specificity varied between 68 and 96% [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Higher cutoffs, such as 65.98&#8211;99.6 pg/mL, showed sensitivity between 68% and 87.6%, with specificity up to 91.3% [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. For very high cutoffs (&#8805;&#8201;130 pg/mL), Raynor et al. reported 100% sensitivity but poor specificity (28%), while Rupin et al. at 200 pg/mL maintained 100% sensitivity with improved specificity (78%) [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. On the contrary, Maaboud et al. used a cutoff value of 160 pg/mL, reporting a lower sensitivity (89%) and an excellent specificity (92.2%) [<xref ref-type="bibr" rid="CR41">41</xref>]. Notably, one study reported 100% sensitivity with the lowest cutoff value (7 ng/mL), but with low specificity (34.48%) [<xref ref-type="bibr" rid="CR18">18</xref>].
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;2</label><caption><p>Details of diagnostic testing</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">ID</th><th align="left" colspan="1" rowspan="1">Standard reference</th><th align="left" colspan="1" rowspan="1">Test used</th><th align="left" colspan="1" rowspan="1">IL-6 cutoff</th><th align="left" colspan="1" rowspan="1">Sensitivity (%)</th><th align="left" colspan="1" rowspan="1">Specificity (%)</th><th align="left" colspan="1" rowspan="1">AUC (95% CI)</th><th align="left" colspan="1" rowspan="1">PPV (%)</th><th align="left" colspan="1" rowspan="1">NPV (%)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"> Chen 2025</td><td align="left" colspan="1" rowspan="1">Positive blood culture&#8203;</td><td align="left" colspan="1" rowspan="1">ELISA</td><td align="left" colspan="1" rowspan="1">44.487&#160;pg/mL for NS-PIs and 43.422&#160;pg/mL for NS-TIs</td><td align="left" colspan="1" rowspan="1">68% for NS-PIs,60% for NS-TIs</td><td align="left" colspan="1" rowspan="1">95% for NS-PIs, 96% for NS-TIs</td><td align="left" colspan="1" rowspan="1">0.817 (NS-PIs) and 0.801 (NS-TIs)&#8203;</td><td align="left" colspan="1" rowspan="1">0.932 for NS-PIs, 0.967 for NS-Tis</td><td align="left" colspan="1" rowspan="1">0.750 for NS-PIs, 0.784 for NS-Tis</td></tr><tr><td align="left" colspan="1" rowspan="1">Santos 2024</td><td align="left" colspan="1" rowspan="1">Positive blood cultures</td><td align="left" colspan="1" rowspan="1">ELISA</td><td align="left" colspan="1" rowspan="1">10&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">96.20%</td><td align="left" colspan="1" rowspan="1">90.9%</td><td align="left" colspan="1" rowspan="1">0.985</td><td align="left" colspan="1" rowspan="1">93.50%</td><td align="left" colspan="1" rowspan="1">45.50%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Goyal 2024</td><td align="left" colspan="1" rowspan="1">Positive blood culture</td><td align="left" colspan="1" rowspan="1">point-of-care (POC) testing with the AFIAS-6</td><td align="left" colspan="1" rowspan="1">7&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">100%</td><td align="left" colspan="1" rowspan="1">34.48%</td><td align="left" colspan="1" rowspan="1">0.55</td><td align="left" colspan="1" rowspan="1">36.67%</td><td align="left" colspan="1" rowspan="1">100%</td></tr><tr><td align="left" colspan="1" rowspan="1">Rupin 2024</td><td align="left" colspan="1" rowspan="1">Positive blood culture</td><td align="left" colspan="1" rowspan="1">Customized multiplex Luminex&#174; assay</td><td align="left" colspan="1" rowspan="1">200&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">100%</td><td align="left" colspan="1" rowspan="1">78%</td><td align="left" colspan="1" rowspan="1">0.68</td><td align="left" colspan="1" rowspan="1">75%</td><td align="left" colspan="1" rowspan="1">100%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Gatseva 2023</td><td align="left" colspan="1" rowspan="1">Positive culture</td><td align="left" colspan="1" rowspan="1">ELISA</td><td align="left" colspan="1" rowspan="1">&#8201;&#8805;&#8201;27.5&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">78%</td><td align="left" colspan="1" rowspan="1">70%</td><td align="left" colspan="1" rowspan="1">0.752</td><td align="left" colspan="1" rowspan="1">58.33%</td><td align="left" colspan="1" rowspan="1">85.53%</td></tr><tr><td align="left" colspan="1" rowspan="1">Kung 2023</td><td align="left" colspan="1" rowspan="1">Blood culture</td><td align="left" colspan="1" rowspan="1">Vitros 250, Ortho Clinical Diagnostics, and Cobas 6000, Roche)</td><td align="left" colspan="1" rowspan="1">30&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">75%</td><td align="left" colspan="1" rowspan="1">82%</td><td align="left" colspan="1" rowspan="1">0.9</td><td align="left" colspan="1" rowspan="1">60%</td><td align="left" colspan="1" rowspan="1">90%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Pons 2023</td><td align="left" colspan="1" rowspan="1">Positive blood culture</td><td align="left" colspan="1" rowspan="1">ELLA Automated Immunoassay System</td><td align="left" colspan="1" rowspan="1">N.D</td><td align="left" colspan="1" rowspan="1">0.89</td><td align="left" colspan="1" rowspan="1">100%</td><td align="left" colspan="1" rowspan="1">0.864 (0.798&#8211;0.929)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Cui 2021</td><td align="left" colspan="1" rowspan="1">Positive blood culture</td><td align="left" colspan="1" rowspan="1">ELISA</td><td align="left" colspan="1" rowspan="1">99.6&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">87.60%</td><td align="left" colspan="1" rowspan="1">91.30%</td><td align="left" colspan="1" rowspan="1">0.888</td><td align="left" colspan="1" rowspan="1">96.30%</td><td align="left" colspan="1" rowspan="1">71.80%</td></tr><tr><td align="left" colspan="1" rowspan="1"> De&#287;irmencio&#287;lu 2019</td><td align="left" colspan="1" rowspan="1">Positive blood culture</td><td align="left" colspan="1" rowspan="1">IMMULITE 1000 analyzer</td><td align="left" colspan="1" rowspan="1">23.22&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">94.40%</td><td align="left" colspan="1" rowspan="1">78.20%</td><td align="left" colspan="1" rowspan="1">0.959</td><td align="left" colspan="1" rowspan="1">75%</td><td align="left" colspan="1" rowspan="1">95.40%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Saldir 2015</td><td align="left" colspan="1" rowspan="1">Positive blood or CSF cultures for microorganisms</td><td align="left" colspan="1" rowspan="1">ELISA</td><td align="left" colspan="1" rowspan="1">7&#160;ng/mL</td><td align="left" colspan="1" rowspan="1">93.30%</td><td align="left" colspan="1" rowspan="1">95%</td><td align="left" colspan="1" rowspan="1">0.96 (95% CI&#8201;=&#8201;0.908&#8211;0.998, p&#8201;&lt;&#8201;0.001)</td><td align="left" colspan="1" rowspan="1">96.60%</td><td align="left" colspan="1" rowspan="1">90.50%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Tunc 2014</td><td align="left" colspan="1" rowspan="1">Positive blood or CSF cultures for microorganisms</td><td align="left" colspan="1" rowspan="1">ELISA</td><td align="left" colspan="1" rowspan="1">7&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">96.70%</td><td align="left" colspan="1" rowspan="1">95%</td><td align="left" colspan="1" rowspan="1">0.97 (95% CI&#8201;=&#8201;0.918&#8211;0.998)</td><td align="left" colspan="1" rowspan="1">96.70%</td><td align="left" colspan="1" rowspan="1">95%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Lusyati 2013</td><td align="left" colspan="1" rowspan="1">Blood culture (BACTEC method)</td><td align="left" colspan="1" rowspan="1">Invitrogen-immunoassays-Luminex&#8482; 100</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;93</td><td align="left" colspan="1" rowspan="1">72.22%</td><td align="left" colspan="1" rowspan="1">72.22%</td><td align="left" colspan="1" rowspan="1">N.D</td><td align="left" colspan="1" rowspan="1">N.D</td><td align="left" colspan="1" rowspan="1">N.D</td></tr><tr><td align="left" colspan="1" rowspan="1">Maaboud 2012</td><td align="left" colspan="1" rowspan="1">Blood culture</td><td align="left" colspan="1" rowspan="1">ELISA</td><td align="left" colspan="1" rowspan="1">160&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">89%</td><td align="left" colspan="1" rowspan="1">92.20%</td><td align="left" colspan="1" rowspan="1">N.D</td><td align="left" colspan="1" rowspan="1">96.70%</td><td align="left" colspan="1" rowspan="1">84.80%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Raynor 2012</td><td align="left" colspan="1" rowspan="1">Positive blood culture</td><td align="left" colspan="1" rowspan="1">multiplex antibody-coated bead array with dual-laser fluorometric detection</td><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;130&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">100%</td><td align="left" colspan="1" rowspan="1">93%</td><td align="left" colspan="1" rowspan="1">N.D</td><td align="left" colspan="1" rowspan="1">38%</td><td align="left" colspan="1" rowspan="1">100%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Hotoura 2011</td><td align="left" colspan="1" rowspan="1">Positive blood culture</td><td align="left" colspan="1" rowspan="1">ELISA</td><td align="left" colspan="1" rowspan="1">30&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">100%</td><td align="left" colspan="1" rowspan="1">74%</td><td align="left" colspan="1" rowspan="1">0.95</td><td align="left" colspan="1" rowspan="1">40%</td><td align="left" colspan="1" rowspan="1">100%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Sarafidis 2010</td><td align="left" colspan="1" rowspan="1">Positive blood culture for microbes or fungi</td><td align="left" colspan="1" rowspan="1">ELISA</td><td align="left" colspan="1" rowspan="1">65.98&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">80%</td><td align="left" colspan="1" rowspan="1">81%</td><td align="left" colspan="1" rowspan="1">0.892 (95% CI: 0.808&#8211;0.976)</td><td align="left" colspan="1" rowspan="1">86%</td><td align="left" colspan="1" rowspan="1">74%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Ng 2007</td><td align="left" colspan="1" rowspan="1">Positive blood cultures</td><td align="left" colspan="1" rowspan="1">Cytometric Bead Array&#160;Kit and Flow Cytometry</td><td align="left" colspan="1" rowspan="1">26.1&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">82%</td><td align="left" colspan="1" rowspan="1">82%</td><td align="left" colspan="1" rowspan="1">0.88</td><td align="left" colspan="1" rowspan="1">64%</td><td align="left" colspan="1" rowspan="1">92%</td></tr><tr><td align="left" colspan="1" rowspan="1">Maciolek 2006</td><td align="left" colspan="1" rowspan="1">Positive blood culture for bacterial infection or RT-PCR for enterovirus</td><td align="left" colspan="1" rowspan="1">Fully automated chemiluminescence assay</td><td align="left" colspan="1" rowspan="1">&#8201;&#8805;&#8201;60&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">68%</td><td align="left" colspan="1" rowspan="1">76%</td><td align="left" colspan="1" rowspan="1">N.D</td><td align="left" colspan="1" rowspan="1">78%</td><td align="left" colspan="1" rowspan="1">65%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Arnon 2005</td><td align="left" colspan="1" rowspan="1">Positive blood cultures</td><td align="left" colspan="1" rowspan="1">ELISA</td><td align="left" colspan="1" rowspan="1">31&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">78%</td><td align="left" colspan="1" rowspan="1">89%</td><td align="left" colspan="1" rowspan="1">0.65 (0.35&#8211;0.76)</td><td align="left" colspan="1" rowspan="1">64%</td><td align="left" colspan="1" rowspan="1">88%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Gonzalez 2003</td><td align="left" colspan="1" rowspan="1">Blood cultures</td><td align="left" colspan="1" rowspan="1">ELISA</td><td align="left" colspan="1" rowspan="1">18&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">75%</td><td align="left" colspan="1" rowspan="1">68%</td><td align="left" colspan="1" rowspan="1">N.D</td><td align="left" colspan="1" rowspan="1">50%</td><td align="left" colspan="1" rowspan="1">87%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Ng 2002</td><td align="left" colspan="1" rowspan="1">Positive cultures (blood, CSF, urine)</td><td align="left" colspan="1" rowspan="1">ELISA</td><td align="left" colspan="1" rowspan="1">31&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">78%</td><td align="left" colspan="1" rowspan="1">92%</td><td align="left" colspan="1" rowspan="1">N.D</td><td align="left" colspan="1" rowspan="1">81%</td><td align="left" colspan="1" rowspan="1">91%</td></tr><tr><td align="left" colspan="1" rowspan="1"> Ng 1997</td><td align="left" colspan="1" rowspan="1">Positive blood culture</td><td align="left" colspan="1" rowspan="1">ELISA</td><td align="left" colspan="1" rowspan="1">31&#160;pg/mL</td><td align="left" colspan="1" rowspan="1">89%</td><td align="left" colspan="1" rowspan="1">96%</td><td align="left" colspan="1" rowspan="1">N.D</td><td align="left" colspan="1" rowspan="1">95%</td><td align="left" colspan="1" rowspan="1">91%</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">ELISA</italic> enzyme-linked immunosorbent assay, <italic toggle="yes">IMMULITE1000</italic> IMMULITE 1000&#8217;s enzyme-amplified chemiluminescence, <italic toggle="yes">CSF</italic> cerebrospinal fluid, <italic toggle="yes">CRP</italic> C-reactive protein, <italic toggle="yes">PCT</italic> procalcitonin, <italic toggle="yes">IL-6</italic> interleukin-6, <italic toggle="yes">LOS</italic> late onset-sepsis, <italic toggle="yes">AUC</italic> area under curve, <italic toggle="yes">ADM</italic> adrenomedullin, <italic toggle="yes">PCR</italic> polymerase chain reaction, <italic toggle="yes">NS-PI</italic> neonatal sepsis-premature infant, <italic toggle="yes">NS-TI</italic> neonatal sepsis-term infant, <italic toggle="yes">N.D</italic> not determined, <italic toggle="yes">CI</italic> confidence interval</p></table-wrap-foot></table-wrap></p><p id="Par20">Two studies were excluded from the meta-analysis due to their exclusive focus on Gram-negative sepsis, limiting their generalizability to the broader neonatal sepsis population. Rupin et al. (2024) evaluated 118 very low birth weight infants within the first week of life and reported that IL-6, at a cutoff of 200&#8239;pg/mL, achieved 100% sensitivity and 78% specificity for diagnosing gram-negative sepsis or necrotizing enterocolitis. The study emphasized the enhanced diagnostic accuracy when IL-6 was combined with the Pulse Oximetry Warning Score [<xref ref-type="bibr" rid="CR19">19</xref>]. Raynor et al. (2012) assessed 226 samples from 163 NICU infants and demonstrated that cytokine screening (including IL-6) yielded 100% sensitivity and 69% PPV for Gram-negative bacteremia [<xref ref-type="bibr" rid="CR46">46</xref>]. Both studies, while supporting the diagnostic utility of IL-6, were excluded due to their selective pathogen focus, which introduces threshold and spectrum biases not compatible with pooled estimates intended to reflect sepsis of all etiologies.</p></sec><sec id="Sec10"><title>Quality and certainty of evidence</title><p id="Par21">The methodological quality of the included studies was assessed using the QUADAS-2 tool. Overall, 13 studies (59.1%) were judged to have low risk of bias, 7 studies (31.8%) had moderate risk, and 2 studies (9.1%) had high risk of bias. The most common concerns were related to the reference standard domain. Full domain-level assessments are presented in Table <xref rid="MOESM1" ref-type="media">S2</xref>.</p><p id="Par22">We also assessed the certainty of the evidence using the GRADE approach for diagnostic test accuracy. Certainty was rated as moderate for both sensitivity (true positives) and specificity (true negatives), mainly due to suspected publication bias detected through asymmetry in the trim-and-fill funnel plot. Other domains (risk of bias, indirectness, inconsistency, and imprecision) were not considered serious. Detailed GRADE ratings are provided in Table <xref rid="MOESM1" ref-type="media">S3</xref>.</p></sec><sec id="Sec11"><title>Meta-analysis</title><sec id="Sec12"><title>Descriptive analysis</title><p id="Par23">The current meta-analysis included a total of 20 studies with a total of 3527 recruited study participants. Table <xref rid="MOESM1" ref-type="media">S4</xref> shows the sensitivity, specificity, and diagnostic odds ratio reported per each study. Most studies reported very good to excellent sensitivity (&gt;&#8201;=&#8201;80%; 13/20 studies) as well as specificity (14/20 studies) with diagnostic odds ratio (DOR) being larger than 30 in most of the studies (15/20 studies). Such a remarkable diagnostic performance of IL-6 also yielded a notable pattern on the summary ROC (SROC) curve of included studies (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>) with a tendency towards the upper left part of the figure (high sensitivity and specificity region). The actual contingency table frequencies are presented in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>, with studies being arranged in a descending order of the reported sensitivity values in order to simplify the overall interpretation of our included data. Upon formal evaluation, no evidence of potential publication bias was detected (Spearman&#8217;s rho between sensitivity and false-positive rate: 0.074; <italic toggle="yes">p</italic>-value: 0.757).<fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>Summary ROC of diagnostic odds ratio as per included studies (n: 20 studies)</p></caption><graphic id="MO2" position="float" orientation="portrait" xlink:href="431_2025_6409_Fig2_HTML.jpg"/></fig><fig id="Fig3" position="float" orientation="portrait"><label>Fig.&#160;3</label><caption><p>Forest plot included studies (n: 20 studies)</p></caption><graphic id="MO3" position="float" orientation="portrait" xlink:href="431_2025_6409_Fig3_HTML.jpg"/></fig></p></sec><sec id="Sec13"><title>Bivariate analysis</title><p id="Par24">Table <xref rid="MOESM1" ref-type="media">S5</xref> presents findings of the bivariate model fit to pool the overall diagnostic test performance metrics of IL-6 after correcting for the potential threshold effect and correlating nature of the diagnostic performance metrics. The model pooled an estimated very good sensitivity of 85.2% (95% CI: 80% to 89.3%) with a similarly encouraging specificity of 84.1% (95% CI: 77.5% to 89%). Such an excellent diagnostic performance is also reflected upon the positive and negative likelihood ratios (LR&#8201;+&#8201;and LR-, respectively). Our analysis revealed a LR&#8201;+&#8201;of 5.43 (95% CI: 3.81 to 7.63) and a LR- of 0.18 (95% CI: 0.13 to 0.24), highlighting the diagnostic value of IL-6 in correct stratification of suspected cases. All these metrics may be summarized via the pooled DOR of 31.4 (95% CI: 18.6 to 49.8) and the 91% area under the curve coverage. Estimated heterogeneity was accepted (I^2: 13.8%). Figure&#160;<xref rid="Fig4" ref-type="fig">4</xref> provides a visual stand-alone summary of these findings.<fig id="Fig4" position="float" orientation="portrait"><label>Fig.&#160;4</label><caption><p>Summary ROC of pooled IL-6 diagnostic odds ratio</p></caption><graphic id="MO4" position="float" orientation="portrait" xlink:href="431_2025_6409_Fig4_HTML.jpg"/></fig></p><p id="Par25">Table <xref rid="MOESM1" ref-type="media">S5</xref> also shows that although our included studies (n: 20) had a study with high ROB (n: 1) and 5 studies which are not prospective cohort (2 prospective case&#8211;control, 1 retrospective cohort, 1 retrospective case&#8211;control, 1 mixed retro- and prospective cohort), our pooled results were not sensitive to their exclusion. This is made clear due to the overlapping 95% CIs of all of the pooled sensitivity, specificity, LR&#8201;+, LR-, and DOR. Moreover, the range of AUC and I^2 variation across the three models was minimal.</p><p id="Par26">Additionally, the Fagan nomogram provided in Figure <xref rid="MOESM1" ref-type="media">S1</xref> goes a step further down the road. Given our pre-test probability of being septic among the cases recruited in our included studies and the excellent LR&#8201;+&#8201;and LR- performance, the post-test probability of having the disease becomes clearer. On the nomogram, the post-test probability that a case with high IL-6 levels suggestive of LONS increases to up to 67%. In contrast, the probability of being a LONS case after a negative IL-6 test becomes as small as 6%.</p><p id="Par27">However, Figure <xref rid="MOESM1" ref-type="media">S2</xref> shows that potential publication bias is speculated. The trim and fill funnel plot estimated that several studies with comparatively small effect sizes could have been left unpublished/trimmed from the plot. The asymmetrical shape of the plot suggests that publication bias can&#8217;t be ignored.</p></sec></sec></sec><sec id="Sec14"><title>Discussion</title><p id="Par28">The key step for managing neonatal sepsis is the early diagnosis and timely prompt initiation of treatment. Therefore, identifying a quick, sensitive, and specific biomarker is crucial for optimizing care. IL-6 rises sharply within 2 to 3 h in response to endotoxin and declines rapidly within 8 h, making it a valuable early marker for sepsis detection [<xref ref-type="bibr" rid="CR51">51</xref>]. This meta-analysis pooled the diagnostic accuracy metrics of IL-6 in diagnosing LONS. Using a bivariate random-effects model, we estimated pooled sensitivity and specificity at 85.2% and 84.1%, respectively. To contextualize these results clinically, we utilized a Fagan nomogram to translate likelihood ratios into post-test probabilities. A positive IL-6 test result increased the post-test probability of LONS to 67%, whereas a negative result decreased it to 6%. These results suggest that IL-6 can meaningfully alter clinical decision-making in NICU settings, supporting its utility in both ruling in and ruling out sepsis.</p><p id="Par29">While these results support the diagnostic utility of IL-6, claims of &#8220;reliability&#8221; should still be moderated due to the observed variability in test characteristics across studies, despite the low statistical heterogeneity (<italic toggle="yes">I</italic><sup>2</sup>&#8201;=&#8201;13.8%). This variability may be attributed to several methodological and clinical factors. First, the wide range of IL-6 cut-off values likely influenced diagnostic performance. While lower thresholds typically increase sensitivity at the expense of specificity, and higher thresholds do the opposite, this expected trend was not consistent across the included studies. For instance, some studies using low cut-offs (e.g., 7 pg/mL) achieved unexpectedly high specificity, whereas others using high cut-offs reported excellent sensitivity [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Second, differences in patient populations&#8212;including gestational age, birth weight, and clinical status&#8212;may alter baseline IL-6 levels and affect performance. Third, the timing of IL-6 measurement relative to symptom onset could impact its diagnostic accuracy. Lastly, although blood culture was used as the reference standard across studies, variations in culture techniques, blood volume drawn, and prior antibiotic exposure may have influenced the confirmation of sepsis, thereby affecting sensitivity and specificity estimates.</p><p id="Par30">Our meta-analysis aligns with the previous findings of Eichberger et al., who reported pooled sensitivity and specificity of 88% and 78%, respectively, from 15 studies [<xref ref-type="bibr" rid="CR52">52</xref>]. Their subgroup analysis showed higher sensitivity in preterm (87%) versus term/mixed infants (82%), while specificity remained the same (86%). Unlike Eichberger et al., our meta-analysis includes more recent studies and focuses on IL-6 accuracy alone, excluding combined biomarkers. Sun et al. conducted a meta-analysis on early-onset sepsis, reporting pooled sensitivity and specificity of 88% and 82% [<xref ref-type="bibr" rid="CR53">53</xref>]. Another meta-analysis focused on sepsis in neonates with premature rupture of membranes found an overall sensitivity of 85% and specificity of 88%, with early/late-onset cases showing higher sensitivity (93% vs. 80%) and specificity (98% vs. 86%) than early-onset cases [<xref ref-type="bibr" rid="CR54">54</xref>].</p><p id="Par31">The diagnostic performance of IL-6 appears to be better than that of conventional inflammatory markers, including CRP and PCT, with emphasis mainly on its earlier rise. Pons et al. reported the accuracy of various biomarkers in LONS: PCT, IL-6, IL-10, IL-27, cluster of differentiation 14 (CD14), neutrophil gelatinase-associated lipocalin (NGAL), interferon gamma-induced protein 10 (IP-10), pentraxin 3 (PTX3), and lipopolysaccharide-binding protein (LBP), gelsolin, and calprotectin. They highlighted IL-6, IL-10, and NGAL as the best biomarkers, with area under the curve of 86%, 84.5%, and 82.9%, respectively [<xref ref-type="bibr" rid="CR20">20</xref>]. A recent study by Chen et al. compared the diagnostic power of IL-6, IL-8, serum amyloid A (SAA), CRP, and PCT [<xref ref-type="bibr" rid="CR33">33</xref>]. They reported that IL-6, IL-8, and SAA, unlike PCT or CRP, had better diagnostic accuracy. PCT combined with IL-6 gave better accuracy for term infants with sepsis [<xref ref-type="bibr" rid="CR33">33</xref>]. Similarly, Cui et al. reported sensitivity and specificity higher than 85% when PCT or CRP was combined with IL-6 [<xref ref-type="bibr" rid="CR34">34</xref>]. Degirmencioglu et al. observed the highest accuracy parameters of IL-6 (AUC of 0.959, 94.4% sensitivity, and 78.2% specificity) compared to presepsin (AUC 0.939, 88.9% sensitivity and specificity), CRP (AUC 0.850, 72.2% sensitivity, 81.5% specificity), and Fetuin-A (AUC 0.612, 72.2% sensitivity, 48.1% specificity) [<xref ref-type="bibr" rid="CR35">35</xref>]. On the contrary, a recent study reported higher accuracy of CRP and PCT over IL-6 when using point-of-care testing [<xref ref-type="bibr" rid="CR18">18</xref>]. This may be attributed to the rapid turnaround and reduced sample handling in POC testing, which minimizes pre-analytical variability and allows for more timely and potentially more accurate detection.</p><p id="Par32">Defining the optimal cutoff value of IL-6 is continuously investigated. Kung et al. reported that the use of IL-6 cutoff of 80 picograms per milliliter (pg/mL) on day 1, 40 pg/mL on days 2 to 7, and 30 pg/mL after day 7 produced sensitivity and specificity of 75% and 81% for culture-confirmed sepsis, respectively [<xref ref-type="bibr" rid="CR40">40</xref>]. As previously discussed, the IL-6 cutoff values did not follow a consistent trend across studies. Chen et al. employed a cutoff level of 44.487 pg/mL for premature infants and 43.422 pg/mL for term infants, reporting sensitivities of 68% and 60%, while specificities were 95% and 96%, respectively [<xref ref-type="bibr" rid="CR33">33</xref>]. Rupin et al. set a far higher cutoff of 200 pg/mL, achieving 100% sensitivity against a specificity of 78% [<xref ref-type="bibr" rid="CR19">19</xref>]. The highest accuracy metrics were reported by Santos et al., Sladir et al., and Tunk et al., using cutoff values of 7 and 10 pg/mL, with sensitivity and specificity over 90% [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. This highlights the superiority of lower cutoff values in diagnosing LONS. However, Goyal et al. chose a cutoff of 7 pg/mL, reporting a sensitivity of 100% but a considerably lower specificity of 34.48% [<xref ref-type="bibr" rid="CR18">18</xref>].</p><p id="Par33">Although the included studies in the current meta-analysis varied in their IL-6 cut-off values, we found no evidence of a significant threshold effect based on the Spearman correlation between the logit of sensitivity and the logit of 1-specificity. This suggests that the variation in diagnostic accuracy is unlikely to be solely due to threshold differences. While we considered incorporating the IL-6 cut-off value as a covariate in an HSROC model, the analysis was not pursued due to the highly skewed distribution of thresholds&#8212;with over two-thirds of studies using values&#8201;&#8805;&#8201;20 pg/mL&#8212;which would have compromised the interpretability and power of such a model. Therefore, while threshold variability remains a plausible contributor to heterogeneity, it could not be formally explored through stratified analysis in this meta-analysis.</p><p id="Par34">Our work has several strengths, including the use of robust analytic methods such as bivariate random-effects modeling, formal assessment for threshold effect, and pre-specified subgroup analyses. In addition, the use of Fagan analysis is a strength of this review, as it bridges statistical accuracy with bedside utility&#8212;especially relevant in high-stakes neonatal care. The change in post-test probabilities demonstrates that IL-6 can enhance the clinician&#8217;s confidence in decision-making, particularly when used alongside clinical judgment and other markers. Lastly, we applied the GRADE approach for diagnostic test accuracy to evaluate the certainty of evidence for both sensitivity and specificity&#8212;an essential yet often overlooked step in diagnostic meta-analyses. This enhances the interpretability and credibility of our findings.</p><p id="Par35">Several limitations must be acknowledged. First, although IL-6 cutoff values varied widely across the included studies, we found no significant threshold effect based on Spearman correlation, and the low statistical heterogeneity (<italic toggle="yes">I</italic><sup>2</sup>&#8201;=&#8201;13.8%) suggests that this variability did not meaningfully affect the pooled estimates. However, due to the skewed distribution of thresholds, we were unable to perform a formal subgroup analysis using HSROC modeling. Second, the possibility of publication bias cannot be excluded, as suggested by the asymmetry in the trim-and-fill funnel plot, which may lead to overestimation of diagnostic accuracy. Third, most included studies were conducted in middle- and high-income countries, limiting generalizability to lower-resource settings where neonatal sepsis epidemiology and care infrastructure may differ. Also, the focus on English-language studies represents a potential limitation, as it may have excluded relevant research published in other languages. Despite these limitations, the diagnostic performance of IL-6 remained consistent and robust across multiple analyses. Future research should focus on validating standardized cutoff values and evaluating IL-6 performance in broader clinical and geographical contexts.</p></sec><sec id="Sec15"><title>Conclusion</title><p id="Par36">IL-6 is a biomarker with high sensitivity and specificity for late-onset neonatal sepsis, with good rule-in and rule-out potential. Its rapid rise during infection makes it clinically useful and practical for detecting early sepsis. Further research should aim to identify and define an optimal threshold and validate IL-6 performance in various neonatal populations to improve reliability in clinical practice.</p></sec><sec id="Sec16" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xlink:href="431_2025_6409_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Material 1 (DOCX&#160;90.9 KB)</p></caption></media></supplementary-material></p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The publication of this article was funded by the Qatar National Library.</p></ack><notes notes-type="author-contribution"><title>Author&#8217;s contributions</title><p>A.N.A.: conceptualization, methodology, data collection, quality assessment, analysis, writing original draft, supervision. M.S.Z.: conceptualization, methodology, analysis, writing original draft. A.A.E.: conceptualization, methodology, data extraction, analysis. S.M.: data collection, data extraction, quality assessment. M.M.: data collection, data extraction, quality assessment. All authors reviewed the manuscript and approved it for publication.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding provided by the Qatar National Library.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval</title><p id="Par37">Not applicable.</p></notes><notes id="FPar2"><title>Consent to participate</title><p id="Par38">Not applicable.</p></notes><notes id="FPar3"><title>Consent for publication</title><p id="Par39">Not applicable.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests</title><p id="Par40">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Singh M, Alsaleem M, Gray CP (2025) Neonatal sepsis. [Updated 2022 Sep 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK531478/">https://www.ncbi.nlm.nih.gov/books/NBK531478/</ext-link><pub-id pub-id-type="pmid">30285373</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawn</surname><given-names>JE</given-names></name><name name-style="western"><surname>Cousens</surname><given-names>S</given-names></name><name name-style="western"><surname>Zupan</surname><given-names>J</given-names></name></person-group><article-title>4 million neonatal deaths: when? where? why?</article-title><source>Lancet</source><year>2005</year><volume>365</volume><issue>9462</issue><fpage>891</fpage><lpage>900</lpage><pub-id pub-id-type="pmid">15752534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(05)71048-5</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Lawn JE, Cousens S, Zupan J (2005) 4 million neonatal deaths: when? where? why? Lancet 365(9462):891&#8211;900<pub-id pub-id-type="pmid">15752534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(05)71048-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fleischmann</surname><given-names>C</given-names></name><etal/></person-group><article-title>Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis</article-title><source>Arch Dis Child</source><year>2021</year><volume>106</volume><issue>8</issue><fpage>745</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">33483376</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/archdischild-2020-320217</pub-id><pub-id pub-id-type="pmcid">PMC8311109</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Fleischmann C et al (2021) Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis. Arch Dis Child 106(8):745&#8211;752<pub-id pub-id-type="pmid">33483376</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/archdischild-2020-320217</pub-id><pub-id pub-id-type="pmcid">PMC8311109</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Rose</surname><given-names>DU</given-names></name><etal/></person-group><article-title>Diagnosis and management of neonatal bacterial sepsis: current challenges and future perspectives</article-title><source>Trop Med Infect Dis</source><year>2024</year><pub-id pub-id-type="pmid">39330888</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/tropicalmed9090199</pub-id><pub-id pub-id-type="pmcid">PMC11435811</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">De Rose DU et al (2024) Diagnosis and management of neonatal bacterial sepsis: current challenges and future perspectives. Trop Med Infect Dis. 10.3390/tropicalmed9090199<pub-id pub-id-type="pmid">39330888</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/tropicalmed9090199</pub-id><pub-id pub-id-type="pmcid">PMC11435811</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boscarino</surname><given-names>G</given-names></name><etal/></person-group><article-title>An overview of antibiotic therapy for early- and late-onset neonatal sepsis: current strategies and future prospects</article-title><source>Antibiotics</source><year>2024</year><pub-id pub-id-type="pmid">38534685</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antibiotics13030250</pub-id><pub-id pub-id-type="pmcid">PMC10967557</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Boscarino G et al (2024) An overview of antibiotic therapy for early- and late-onset neonatal sepsis: current strategies and future prospects. Antibiotics. 10.3390/antibiotics13030250<pub-id pub-id-type="pmid">38534685</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antibiotics13030250</pub-id><pub-id pub-id-type="pmcid">PMC10967557</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schrag</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014</article-title><source>Pediatrics</source><year>2016</year><pub-id pub-id-type="pmid">27940705</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2016-2013</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Schrag SJ et al (2016) Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics. 10.1542/peds.2016-2013<pub-id pub-id-type="pmid">27940705</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2016-2013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zea-Vera</surname><given-names>A</given-names></name><name name-style="western"><surname>Ochoa</surname><given-names>TJ</given-names></name></person-group><article-title>Challenges in the diagnosis and management of neonatal sepsis</article-title><source>J Trop Pediatr</source><year>2015</year><volume>61</volume><issue>1</issue><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">25604489</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/tropej/fmu079</pub-id><pub-id pub-id-type="pmcid">PMC4375388</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Zea-Vera A, Ochoa TJ (2015) Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr 61(1):1&#8211;13<pub-id pub-id-type="pmid">25604489</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/tropej/fmu079</pub-id><pub-id pub-id-type="pmcid">PMC4375388</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gude</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Biomarkers of neonatal sepsis: from being mere numbers to becoming guiding diagnostics</article-title><source>Cureus</source><year>2022</year><volume>14</volume><issue>3</issue><fpage>e23215</fpage><pub-id pub-id-type="pmid">35449688</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.23215</pub-id><pub-id pub-id-type="pmcid">PMC9012212</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Gude SS et al (2022) Biomarkers of neonatal sepsis: from being mere numbers to becoming guiding diagnostics. Cureus 14(3):e23215<pub-id pub-id-type="pmid">35449688</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.23215</pub-id><pub-id pub-id-type="pmcid">PMC9012212</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hisamuddin</surname><given-names>E</given-names></name><etal/></person-group><article-title>Validity of C-reactive protein (CRP) for diagnosis of neonatal sepsis</article-title><source>Pak J Med Sci</source><year>2015</year><volume>31</volume><issue>3</issue><fpage>527</fpage><lpage>531</lpage><pub-id pub-id-type="pmid">26150837</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12669/pjms.313.6668</pub-id><pub-id pub-id-type="pmcid">PMC4485264</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Hisamuddin E et al (2015) Validity of C-reactive protein (CRP) for diagnosis of neonatal sepsis. Pak J Med Sci 31(3):527&#8211;531<pub-id pub-id-type="pmid">26150837</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12669/pjms.313.6668</pub-id><pub-id pub-id-type="pmcid">PMC4485264</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eichberger</surname><given-names>J</given-names></name><name name-style="western"><surname>Resch</surname><given-names>E</given-names></name><name name-style="western"><surname>Resch</surname><given-names>B</given-names></name></person-group><article-title>Diagnosis of neonatal sepsis: the role of inflammatory markers</article-title><source>Front Pediatr</source><year>2022</year><volume>10</volume><fpage>840288</fpage><pub-id pub-id-type="pmid">35345614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fped.2022.840288</pub-id><pub-id pub-id-type="pmcid">PMC8957220</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Eichberger J, Resch E, Resch B (2022) Diagnosis of neonatal sepsis: the role of inflammatory markers. Front Pediatr 10:840288<pub-id pub-id-type="pmid">35345614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fped.2022.840288</pub-id><pub-id pub-id-type="pmcid">PMC8957220</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mustapha</surname><given-names>SS</given-names></name><etal/></person-group><article-title>The role of procalcitonin in neonatal sepsis-examining facts and misconceptions</article-title><source>J Clin Neonatol</source><year>2024</year><volume>13</volume><issue>2</issue><fpage>35</fpage><lpage>41</lpage></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Mustapha SS et al (2024) The role of procalcitonin in neonatal sepsis-examining facts and misconceptions. J Clin Neonatol 13(2):35&#8211;41</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pontrelli</surname><given-names>G</given-names></name><etal/></person-group><article-title>Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis</article-title><source>BMC Infect Dis</source><year>2017</year><volume>17</volume><issue>1</issue><fpage>302</fpage><pub-id pub-id-type="pmid">28438138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12879-017-2396-7</pub-id><pub-id pub-id-type="pmcid">PMC5404674</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Pontrelli G et al (2017) Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis. BMC Infect Dis 17(1):302<pub-id pub-id-type="pmid">28438138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12879-017-2396-7</pub-id><pub-id pub-id-type="pmcid">PMC5404674</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xing</surname><given-names>W</given-names></name><etal/></person-group><article-title>Role of interleukins in the detection of neonatal sepsis: a network meta-analysis</article-title><source>Front Pediatr</source><year>2023</year><volume>11</volume><fpage>1267777</fpage><pub-id pub-id-type="pmid">38027268</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fped.2023.1267777</pub-id><pub-id pub-id-type="pmcid">PMC10652565</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Xing W et al (2023) Role of interleukins in the detection of neonatal sepsis: a network meta-analysis. Front Pediatr 11:1267777<pub-id pub-id-type="pmid">38027268</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fped.2023.1267777</pub-id><pub-id pub-id-type="pmcid">PMC10652565</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sherbiny</surname><given-names>HS</given-names></name><etal/></person-group><article-title>Validity of serum and urinary hepcidin as biomarkers for late-onset sepsis in premature infants</article-title><source>Ther Adv Chronic Dis</source><year>2022</year><volume>13</volume><fpage>20406223221122527</fpage><pub-id pub-id-type="pmid">36093263</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/20406223221122527</pub-id><pub-id pub-id-type="pmcid">PMC9459492</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Sherbiny HS et al (2022) Validity of serum and urinary hepcidin as biomarkers for late-onset sepsis in premature infants. Ther Adv Chronic Dis 13:20406223221122527<pub-id pub-id-type="pmid">36093263</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/20406223221122527</pub-id><pub-id pub-id-type="pmcid">PMC9459492</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Streimish</surname><given-names>I</given-names></name><etal/></person-group><article-title>Neutrophil CD64 as a diagnostic marker in neonatal sepsis</article-title><source>Pediatr Infect Dis J</source><year>2012</year><volume>31</volume><issue>7</issue><fpage>777</fpage><lpage>781</lpage><pub-id pub-id-type="pmid">22481422</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/INF.0b013e318256fb07</pub-id><pub-id pub-id-type="pmcid">PMC3375383</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Streimish I et al (2012) Neutrophil CD64 as a diagnostic marker in neonatal sepsis. Pediatr Infect Dis J 31(7):777&#8211;781<pub-id pub-id-type="pmid">22481422</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/INF.0b013e318256fb07</pub-id><pub-id pub-id-type="pmcid">PMC3375383</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aliyu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach</article-title><source>Int Immunopharmacol</source><year>2022</year><volume>111</volume><fpage>109130</fpage><pub-id pub-id-type="pmid">35969896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.intimp.2022.109130</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Aliyu M et al (2022) Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach. Int Immunopharmacol 111:109130<pub-id pub-id-type="pmid">35969896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.intimp.2022.109130</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><etal/></person-group><article-title>The value of interleukin-6 (IL-6) within 6 hours after birth in the prompt diagnosis of early-onset neonatal sepsis</article-title><source>Transl Pediatr</source><year>2020</year><volume>9</volume><issue>5</issue><fpage>629</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">33209725</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/tp-20-239</pub-id><pub-id pub-id-type="pmcid">PMC7658759</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Liu C et al (2020) The value of interleukin-6 (IL-6) within 6 hours after birth in the prompt diagnosis of early-onset neonatal sepsis. Transl Pediatr 9(5):629&#8211;635<pub-id pub-id-type="pmid">33209725</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/tp-20-239</pub-id><pub-id pub-id-type="pmcid">PMC7658759</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goyal</surname><given-names>M</given-names></name><etal/></person-group><article-title>Diagnostic accuracy of point-of-care testing of c-reactive protein, interleukin-6, and procalcitonin in neonates with clinically suspected sepsis: a prospective observational study</article-title><source>Med Princ Pract</source><year>2024</year><volume>33</volume><issue>3</issue><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">38320541</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000536678</pub-id><pub-id pub-id-type="pmcid">PMC11175603</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Goyal M et al (2024) Diagnostic accuracy of point-of-care testing of c-reactive protein, interleukin-6, and procalcitonin in neonates with clinically suspected sepsis: a prospective observational study. Med Princ Pract 33(3):291&#8211;298<pub-id pub-id-type="pmid">38320541</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000536678</pub-id><pub-id pub-id-type="pmcid">PMC11175603</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>R</given-names></name><etal/></person-group><article-title>Inflammatory biomarkers and physiomarkers of late-onset sepsis and necrotizing enterocolitis in premature infants</article-title><source>Front Pediatr</source><year>2024</year><volume>12</volume><fpage>1337849</fpage><pub-id pub-id-type="pmid">38312920</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fped.2024.1337849</pub-id><pub-id pub-id-type="pmcid">PMC10834753</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Kumar R et al (2024) Inflammatory biomarkers and physiomarkers of late-onset sepsis and necrotizing enterocolitis in premature infants. Front Pediatr 12:1337849<pub-id pub-id-type="pmid">38312920</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fped.2024.1337849</pub-id><pub-id pub-id-type="pmcid">PMC10834753</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pons</surname><given-names>S</given-names></name><etal/></person-group><article-title>Performance of 11 host biomarkers alone or in combination in the diagnosis of late-onset sepsis in hospitalized neonates: the prospective EMERAUDE study</article-title><source>Biomedicines</source><year>2023</year><pub-id pub-id-type="pmid">37371798</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biomedicines11061703</pub-id><pub-id pub-id-type="pmcid">PMC10295850</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Pons S et al (2023) Performance of 11 host biomarkers alone or in combination in the diagnosis of late-onset sepsis in hospitalized neonates: the prospective EMERAUDE study. Biomedicines. 10.3390/biomedicines11061703<pub-id pub-id-type="pmid">37371798</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biomedicines11061703</pub-id><pub-id pub-id-type="pmcid">PMC10295850</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lusyati</surname><given-names>S</given-names></name><etal/></person-group><article-title>Cytokines patterns in newborn infants with late onset sepsis</article-title><source>J Neonatal-Perinatal Med</source><year>2013</year><volume>6</volume><issue>2</issue><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">24246518</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/NPM-1364112</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Lusyati S et al (2013) Cytokines patterns in newborn infants with late onset sepsis. Journal of Neonatal-Perinatal Medicine 6(2):153&#8211;163<pub-id pub-id-type="pmid">24246518</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/NPM-1364112</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Page</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title><source>BMJ</source><year>2021</year><volume>372</volume><fpage>n71</fpage><pub-id pub-id-type="pmid">33782057</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmcid">PMC8005924</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71<pub-id pub-id-type="pmid">33782057</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmcid">PMC8005924</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whiting</surname><given-names>PF</given-names></name><etal/></person-group><article-title>QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies</article-title><source>Ann Intern Med</source><year>2011</year><volume>155</volume><issue>8</issue><fpage>529</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">22007046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/0003-4819-155-8-201110180-00009</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Whiting PF et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529&#8211;536<pub-id pub-id-type="pmid">22007046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/0003-4819-155-8-201110180-00009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sch&#252;nemann</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Grade guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy</article-title><source>J Clin Epidemiol</source><year>2020</year><volume>122</volume><fpage>129</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">32060007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jclinepi.2019.12.020</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Sch&#252;nemann HJ et al (2020) Grade guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy. J Clin Epidemiol 122:129&#8211;141<pub-id pub-id-type="pmid">32060007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jclinepi.2019.12.020</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reitsma</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews</article-title><source>J Clin Epidemiol</source><year>2005</year><volume>58</volume><issue>10</issue><fpage>982</fpage><lpage>990</lpage><pub-id pub-id-type="pmid">16168343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jclinepi.2005.02.022</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Reitsma JB et al (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58(10):982&#8211;990<pub-id pub-id-type="pmid">16168343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jclinepi.2005.02.022</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><etal/></person-group><article-title>Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-part part II. statistical methods of meta-analysis</article-title><source>Korean J Radiol</source><year>2015</year><volume>16</volume><issue>6</issue><fpage>1188</fpage><lpage>1196</lpage><pub-id pub-id-type="pmid">26576107</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3348/kjr.2015.16.6.1188</pub-id><pub-id pub-id-type="pmcid">PMC4644739</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Lee J et al (2015) Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-part part II. statistical methods of meta-analysis. Korean J Radiol 16(6):1188&#8211;1196<pub-id pub-id-type="pmid">26576107</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3348/kjr.2015.16.6.1188</pub-id><pub-id pub-id-type="pmcid">PMC4644739</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duval</surname><given-names>S</given-names></name><name name-style="western"><surname>Tweedie</surname><given-names>R</given-names></name></person-group><article-title>A nonparametric &#8220;trim and fill&#8221; method of accounting for publication bias in meta-analysis</article-title><source>J Am Stat Assoc</source><year>2000</year><volume>95</volume><issue>449</issue><fpage>89</fpage><lpage>98</lpage></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Duval S, Tweedie R (2000) A nonparametric &#8220;trim and fill&#8221; method of accounting for publication bias in meta-analysis. J Am Stat Assoc 95(449):89&#8211;98</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>B&#252;rkner</surname><given-names>PC</given-names></name><name name-style="western"><surname>Doebler</surname><given-names>P</given-names></name></person-group><article-title>Testing for publication bias in diagnostic meta-analysis: a simulation study</article-title><source>Stat Med</source><year>2014</year><volume>33</volume><issue>18</issue><fpage>3061</fpage><lpage>3077</lpage><pub-id pub-id-type="pmid">24753050</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/sim.6177</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">B&#252;rkner PC, Doebler P (2014) Testing for publication bias in diagnostic meta-analysis: a simulation study. Stat Med 33(18):3061&#8211;3077<pub-id pub-id-type="pmid">24753050</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/sim.6177</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">R Core Team (2025) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Retrieved from <ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">Doebler P, Holling H (2015) Meta-analysis of diagnostic accuracy with mada. R Packag 1:15</mixed-citation></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viechtbauer</surname><given-names>W</given-names></name></person-group><article-title>Conducting meta-analyses in R with the metafor package</article-title><source>J Stat Softw</source><year>2010</year><volume>36</volume><issue>3</issue><fpage>1</fpage><lpage>48</lpage></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1&#8211;48</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnon</surname><given-names>S</given-names></name><etal/></person-group><article-title>Serum amyloid A protein is a useful inflammatory marker during late-onset sepsis in preterm infants</article-title><source>Biol Neonate</source><year>2005</year><volume>87</volume><issue>2</issue><fpage>105</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">15539766</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000081979</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Arnon S et al (2005) Serum amyloid A protein is a useful inflammatory marker during late-onset sepsis in preterm infants. Biol Neonate 87(2):105&#8211;110<pub-id pub-id-type="pmid">15539766</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000081979</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Comparative analysis of inflammatory biomarkers for the diagnosis of neonatal sepsis: IL-6, IL-8, SAA, CRP, and PCT</article-title><source>Open Life Sci</source><year>2025</year><volume>20</volume><issue>1</issue><fpage>20221005</fpage><pub-id pub-id-type="pmid">39886481</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/biol-2022-1005</pub-id><pub-id pub-id-type="pmcid">PMC11780256</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Chen Y et al (2025) Comparative analysis of inflammatory biomarkers for the diagnosis of neonatal sepsis: IL-6, IL-8, SAA, CRP, and PCT. Open Life Sci 20(1):20221005<pub-id pub-id-type="pmid">39886481</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/biol-2022-1005</pub-id><pub-id pub-id-type="pmcid">PMC11780256</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Cui X et al (2020) The clinical significance of interleukin-6, C-reactive protein, and procalcitonin in the early recognition of nosocomial infections in preterm infants, 01 March 2021, PREPRINT (Version 2) available at Research Square. 10.21203/rs.3.rs-106968/v2</mixed-citation></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De&#287;irmencio&#287;lu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Presepsin and fetuin-A dyad for the diagnosis of proven sepsis in preterm neonates</article-title><source>BMC Infect Dis</source><year>2019</year><volume>19</volume><issue>1</issue><fpage>695</fpage><pub-id pub-id-type="pmid">31387523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12879-019-4316-5</pub-id><pub-id pub-id-type="pmcid">PMC6683331</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">De&#287;irmencio&#287;lu H et al (2019) Presepsin and fetuin-A dyad for the diagnosis of proven sepsis in preterm neonates. BMC Infect Dis 19(1):695<pub-id pub-id-type="pmid">31387523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12879-019-4316-5</pub-id><pub-id pub-id-type="pmcid">PMC6683331</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dos Santos</surname><given-names>EH</given-names></name><name name-style="western"><surname>Barreira</surname><given-names>GA</given-names></name><name name-style="western"><surname>Saippa</surname><given-names>MO</given-names></name><name name-style="western"><surname>Cruz</surname><given-names>MCP</given-names></name><name name-style="western"><surname>Rodrigues</surname><given-names>KA</given-names></name><name name-style="western"><surname>Arkader</surname><given-names>R</given-names></name><name name-style="western"><surname>Okay</surname><given-names>TS</given-names></name></person-group><article-title>Differential roles of interleukin-6 and adrenomedullin in early diagnosis and mortality predictions in late-onset neonatal sepsis</article-title><source>Clinical and experimental pediatrics</source><year>2025</year><volume>68</volume><issue>6</issue><fpage>463</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">39727022</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3345/cep.2024.01543</pub-id><pub-id pub-id-type="pmcid">PMC12146679</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Dos Santos EH, Barreira GA, Saippa MO, Cruz MCP, Rodrigues KA, Arkader R, Okay TS (2025) Differential roles of interleukin-6 and adrenomedullin in early diagnosis and mortality predictions in late-onset neonatal sepsis. Clin Exp Pediatr 68(6):463&#8211;471. 10.3345/cep.2024.01543<pub-id pub-id-type="pmid">39727022</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3345/cep.2024.01543</pub-id><pub-id pub-id-type="pmcid">PMC12146679</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gatseva</surname><given-names>P</given-names></name><etal/></person-group><article-title>Early diagnostic markers of late-onset neonatal sepsis</article-title><source>Pediatr Rep</source><year>2023</year><volume>15</volume><issue>3</issue><fpage>548</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">37755410</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/pediatric15030050</pub-id><pub-id pub-id-type="pmcid">PMC10535522</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Gatseva P et al (2023) Early diagnostic markers of late-onset neonatal sepsis. Pediatr Rep 15(3):548&#8211;559<pub-id pub-id-type="pmid">37755410</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/pediatric15030050</pub-id><pub-id pub-id-type="pmcid">PMC10535522</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonzalez</surname><given-names>BE</given-names></name><etal/></person-group><article-title>Early markers of late-onset sepsis in premature neonates: clinical, hematological and cytokine profile</article-title><source>J Perinat Med</source><year>2003</year><volume>31</volume><issue>1</issue><fpage>60</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">12661146</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/JPM.2003.009</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Gonzalez BE et al (2003) Early markers of late-onset sepsis in premature neonates: clinical, hematological and cytokine profile. J Perinat Med 31(1):60&#8211;68<pub-id pub-id-type="pmid">12661146</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/JPM.2003.009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hotoura</surname><given-names>E</given-names></name><etal/></person-group><article-title>Pre-inflammatory mediators and lymphocyte subpopulations in preterm neonates with sepsis</article-title><source>Inflammation</source><year>2012</year><volume>35</volume><issue>3</issue><fpage>1094</fpage><lpage>1101</lpage><pub-id pub-id-type="pmid">22160841</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10753-011-9416-3</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Hotoura E et al (2012) Pre-inflammatory mediators and lymphocyte subpopulations in preterm neonates with sepsis. Inflammation 35(3):1094&#8211;1101<pub-id pub-id-type="pmid">22160841</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10753-011-9416-3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>K&#252;ng</surname><given-names>E</given-names></name><etal/></person-group><article-title>Cut-off values of serum interleukin-6 for culture-confirmed sepsis in neonates</article-title><source>Pediatr Res</source><year>2023</year><volume>93</volume><issue>7</issue><fpage>1969</fpage><lpage>1974</lpage><pub-id pub-id-type="pmid">36216867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41390-022-02329-9</pub-id><pub-id pub-id-type="pmcid">PMC10313515</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">K&#252;ng E et al (2023) Cut-off values of serum interleukin-6 for culture-confirmed sepsis in neonates. Pediatr Res 93(7):1969&#8211;1974<pub-id pub-id-type="pmid">36216867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41390-022-02329-9</pub-id><pub-id pub-id-type="pmcid">PMC10313515</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Abdel-Maaboud M, El-Mazary AM, Osman AM (2012) Serum calprotectin as a diagnostic marker of late onset sepsis in full-term neonates. The Egyptian Journal of Pediatric Allergy and Immunology 10(1):19&#8211;24. <ext-link ext-link-type="uri" xlink:href="https://www.ajol.info/index.php/ejpai/article/view/108273">https://www.ajol.info/index.php/ejpai/article/view/108273</ext-link></mixed-citation></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>PC</given-names></name><etal/></person-group><article-title>Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants</article-title><source>Arch Dis Child Fetal Neonatal Ed</source><year>1997</year><volume>77</volume><issue>3</issue><fpage>F221</fpage><lpage>F227</lpage><pub-id pub-id-type="pmid">9462194</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/fn.77.3.f221</pub-id><pub-id pub-id-type="pmcid">PMC1720722</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Ng PC et al (1997) Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 77(3):F221&#8211;F227<pub-id pub-id-type="pmid">9462194</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/fn.77.3.f221</pub-id><pub-id pub-id-type="pmcid">PMC1720722</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>PC</given-names></name><etal/></person-group><article-title>IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants</article-title><source>Pediatr Res</source><year>2007</year><volume>61</volume><issue>1</issue><fpage>93</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">17211148</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1203/01.pdr.0000250207.95723.96</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Ng PC et al (2007) IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr Res 61(1):93&#8211;98<pub-id pub-id-type="pmid">17211148</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1203/01.pdr.0000250207.95723.96</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>PC</given-names></name><etal/></person-group><article-title>Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birthweight infants</article-title><source>Pediatr Res</source><year>2002</year><volume>51</volume><issue>3</issue><fpage>296</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">11861933</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1203/00006450-200203000-00006</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Ng PC et al (2002) Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birthweight infants. Pediatr Res 51(3):296&#8211;303<pub-id pub-id-type="pmid">11861933</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1203/00006450-200203000-00006</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramineni</surname><given-names>P</given-names></name><etal/></person-group><article-title>Serum calprotectin as a marker of neonatal sepsis: a hospital-based cross-sectional diagnostic study</article-title><source>F1000Res</source><year>2023</year><volume>12</volume><fpage>626</fpage><pub-id pub-id-type="pmid">37600908</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12688/f1000research.132099.2</pub-id><pub-id pub-id-type="pmcid">PMC10432886</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Ramineni P et al (2023) Serum calprotectin as a marker of neonatal sepsis: a hospital-based cross-sectional diagnostic study. F1000Res 12:626<pub-id pub-id-type="pmid">37600908</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12688/f1000research.132099.2</pub-id><pub-id pub-id-type="pmcid">PMC10432886</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raynor</surname><given-names>LL</given-names></name><etal/></person-group><article-title>Cytokine screening identifies NICU patients with Gram-negative bacteremia</article-title><source>Pediatr Res</source><year>2012</year><volume>71</volume><issue>3</issue><fpage>261</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">22278182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/pr.2011.45</pub-id><pub-id pub-id-type="pmcid">PMC3552187</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Raynor LL et al (2012) Cytokine screening identifies NICU patients with Gram-negative bacteremia. Pediatr Res 71(3):261&#8211;266<pub-id pub-id-type="pmid">22278182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/pr.2011.45</pub-id><pub-id pub-id-type="pmcid">PMC3552187</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saldir</surname><given-names>M</given-names></name><etal/></person-group><article-title>Endocan and soluble triggering receptor expressed on myeloid cells-1 as novel markers for neonatal sepsis</article-title><source>Pediatr Neonatol</source><year>2015</year><volume>56</volume><issue>6</issue><fpage>415</fpage><lpage>421</lpage><pub-id pub-id-type="pmid">26341458</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pedneo.2015.03.006</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Saldir M et al (2015) Endocan and soluble triggering receptor expressed on myeloid cells-1 as novel markers for neonatal sepsis. Pediatr Neonatol 56(6):415&#8211;421<pub-id pub-id-type="pmid">26341458</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pedneo.2015.03.006</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarafidis</surname><given-names>K</given-names></name><etal/></person-group><article-title>Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates</article-title><source>Intensive Care Med</source><year>2010</year><volume>36</volume><issue>5</issue><fpage>864</fpage><lpage>868</lpage><pub-id pub-id-type="pmid">20232048</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00134-010-1819-3</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Sarafidis K et al (2010) Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates. Intensive Care Med 36(5):864&#8211;868<pub-id pub-id-type="pmid">20232048</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00134-010-1819-3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tunc</surname><given-names>T</given-names></name><etal/></person-group><article-title>Diagnostic value of elevated CXCR4 and CXCL12 in neonatal sepsis</article-title><source>J Matern Fetal Neonatal Med</source><year>2015</year><volume>28</volume><issue>3</issue><fpage>356</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">24749796</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/14767058.2014.916683</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Tunc T et al (2015) Diagnostic value of elevated CXCR4 and CXCL12 in neonatal sepsis. J Matern Fetal Neonatal Med 28(3):356&#8211;361<pub-id pub-id-type="pmid">24749796</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/14767058.2014.916683</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verboon-Maciolek</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy</article-title><source>Pediatr Res</source><year>2006</year><volume>59</volume><issue>3</issue><fpage>457</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">16492989</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1203/01.pdr.0000200808.35368.57</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Verboon-Maciolek MA et al (2006) Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatr Res 59(3):457&#8211;461<pub-id pub-id-type="pmid">16492989</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1203/01.pdr.0000200808.35368.57</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effects in humans of intravenously administered endotoxin on soluble cell-adhesion molecule and inflammatory markers: a model of human diseases</article-title><source>Clin Exp Pharmacol Physiol</source><year>2001</year><volume>28</volume><issue>5&#8211;6</issue><fpage>376</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">11380509</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1440-1681.2001.03463.x</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Wilson M et al (2001) Effects in humans of intravenously administered endotoxin on soluble cell-adhesion molecule and inflammatory markers: a model of human diseases. Clin Exp Pharmacol Physiol 28(5&#8211;6):376&#8211;380<pub-id pub-id-type="pmid">11380509</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1440-1681.2001.03463.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eichberger</surname><given-names>J</given-names></name><name name-style="western"><surname>Resch</surname><given-names>E</given-names></name><name name-style="western"><surname>Resch</surname><given-names>B</given-names></name></person-group><article-title>Reliability of IL-6 alone and in combination for diagnosis of late onset sepsis: a systematic review</article-title><source>Children (Basel)</source><year>2024</year><pub-id pub-id-type="pmid">38671704</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/children11040486</pub-id><pub-id pub-id-type="pmcid">PMC11049321</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Eichberger J, Resch E, Resch B (2024) Reliability of IL-6 alone and in combination for diagnosis of late onset sepsis: a systematic review. Children (Basel). 10.3390/children11040486<pub-id pub-id-type="pmid">38671704</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/children11040486</pub-id><pub-id pub-id-type="pmcid">PMC11049321</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>B</given-names></name><etal/></person-group><article-title>A meta-analysis of interleukin-6 as a valid and accurate index in diagnosing early neonatal sepsis</article-title><source>Int Wound J</source><year>2019</year><volume>16</volume><issue>2</issue><fpage>527</fpage><lpage>533</lpage><pub-id pub-id-type="pmid">30734480</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/iwj.13079</pub-id><pub-id pub-id-type="pmcid">PMC7948874</pub-id><related-article related-article-type="retraction-forward" ext-link-type="pmc" xlink:href="PMC12015196"/></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Sun B et al (2019) A meta-analysis of interleukin-6 as a valid and accurate index in diagnosing early neonatal sepsis. Int Wound J 16(2):527&#8211;533<pub-id pub-id-type="pmid">30734480</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/iwj.13079</pub-id><pub-id pub-id-type="pmcid">PMC7948874</pub-id><related-article related-article-type="retraction-forward" ext-link-type="pmc" xlink:href="PMC12015196"/></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Interleukin-6 for early diagnosis of neonatal sepsis with premature rupture of the membranes: a meta-analysis</article-title><source>Medicine</source><year>2018</year><volume>97</volume><issue>47</issue><fpage>e13146</fpage><pub-id pub-id-type="pmid">30461611</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000013146</pub-id><pub-id pub-id-type="pmcid">PMC6392693</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Qiu X et al (2018) Interleukin-6 for early diagnosis of neonatal sepsis with premature rupture of the membranes: a meta-analysis. Medicine 97(47):e13146<pub-id pub-id-type="pmid">30461611</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000013146</pub-id><pub-id pub-id-type="pmcid">PMC6392693</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>